These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
435 related articles for article (PubMed ID: 33031827)
1. CircRNA ITCH increases bortezomib sensitivity through regulating the miR-615-3p/PRKCD axis in multiple myeloma. Liu J; Du F; Chen C; Li D; Chen Y; Xiao X; Hou X Life Sci; 2020 Dec; 262():118506. PubMed ID: 33031827 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of hsa_circ_0003489 shifts balance from autophagy to apoptosis and sensitizes multiple myeloma cells to bortezomib via miR-874-3p/HDAC1 axis. Tian FQ; Chen ZR; Zhu W; Tang MQ; Li JH; Zhang XC; Jiang J; Cheng XH J Gene Med; 2021 Sep; 23(9):e3329. PubMed ID: 33625798 [TBL] [Abstract][Full Text] [Related]
3. The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a. Han D; Wang Y; Wang Y; Dai X; Zhou T; Chen J; Tao B; Zhang J; Cao F Circ Res; 2020 Jul; 127(4):e108-e125. PubMed ID: 32392088 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of circITCH promotes osteosarcoma development and resistance to doxorubicin via the miR-524/RASSF6 axis. Zhou W; Liu Y; Wu X J Gene Med; 2021 Oct; 23(10):e3373. PubMed ID: 34151476 [TBL] [Abstract][Full Text] [Related]
5. hsa-miR-631 resensitizes bortezomib-resistant multiple myeloma cell lines by inhibiting UbcH10. Xi H; Li L; Du J; An R; Fan R; Lu J; Wu YX; Wu SX; Hou J; Zhao LM Oncol Rep; 2017 Feb; 37(2):961-968. PubMed ID: 28000886 [TBL] [Abstract][Full Text] [Related]
6. LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p. Pan Y; Zhang Y; Liu W; Huang Y; Shen X; Jing R; Pu J; Wang X; Ju S; Cong H; Chen H Cell Death Dis; 2019 Feb; 10(2):106. PubMed ID: 30728351 [TBL] [Abstract][Full Text] [Related]
7. Depletion of circ_0007841 inhibits multiple myeloma development and BTZ resistance via miR-129-5p/JAG1 axis. Wang Y; Lin Q; Song C; Ma R; Li X Cell Cycle; 2020 Dec; 19(23):3289-3302. PubMed ID: 33131409 [TBL] [Abstract][Full Text] [Related]
8. Circular RNA circPSAP functions as an efficient miR-331-3p sponge to regulate proliferation, apoptosis and bortezomib sensitivity of human multiple myeloma cells by upregulating HDAC4. Ma H; Shen L; Yang H; Gong H; Du X J Pharmacol Sci; 2022 May; 149(1):27-36. PubMed ID: 35369902 [TBL] [Abstract][Full Text] [Related]
9. MiR-197-3p reduces bortezomib resistance in multiple myeloma by inhibiting IL-6 expression in a MEAF6-dependent manner. Liu Y; Cheng P; Zhao W; Zhu L; Sui J; Dai Y; Lai Y Leuk Res; 2022 Mar; 114():106785. PubMed ID: 35074616 [TBL] [Abstract][Full Text] [Related]
10. Circular RNA CircITCH (has-circ-0001141) suppresses hepatocellular carcinoma (HCC) progression by sponging miR-184. Guo X; Wang Z; Deng X; Lu Y; Huang X; Lin J; Lan X; Su Q; Wang C Cell Cycle; 2022 Aug; 21(15):1557-1577. PubMed ID: 35400275 [TBL] [Abstract][Full Text] [Related]
11. Circular RNA circ-CCT3 promotes bortezomib resistance in multiple myeloma via modulating miR-223-3p/BRD4 axis. Liu D; Wang Y; Li H; Peng S; Tan H; Huang Z Anticancer Drugs; 2022 Jan; 33(1):e145-e154. PubMed ID: 34387610 [TBL] [Abstract][Full Text] [Related]
12. CircRERE confers the resistance of multiple myeloma to bortezomib depending on the regulation of CD47 by exerting the sponge effect on miR-152-3p. Fang W; Mu J; Yang Y; Liu L J Bone Oncol; 2021 Oct; 30():100381. PubMed ID: 34307012 [TBL] [Abstract][Full Text] [Related]
13. LncRNA PRAL is closely related to clinical prognosis of multiple myeloma and the bortezomib sensitivity. Xiao G; Li Y; Wang Y; Zhao B; Zou Z; Hou S; Jia X; Liu X; Yao Y; Wan J; Xiong H Exp Cell Res; 2018 Sep; 370(2):254-263. PubMed ID: 29944867 [TBL] [Abstract][Full Text] [Related]
14. N6-Methyladenosine reader HNRNPC-mediated downregulation of circITCH prevents miR-224-3p sequestering and contributes to tumorigenesis in nasopharyngeal carcinoma. Zhou Q; Song W; Li X; Lin J; Zhu C; Cao L; Li W; Lin S Environ Toxicol; 2024 May; 39(5):2893-2907. PubMed ID: 38299319 [TBL] [Abstract][Full Text] [Related]
15. Lnc NEAT1/miR-29b-3p/Sp1 form a positive feedback loop and modulate bortezomib resistance in human multiple myeloma cells. Che F; Ye X; Wang Y; Ma S; Wang X Eur J Pharmacol; 2021 Jan; 891():173752. PubMed ID: 33253679 [TBL] [Abstract][Full Text] [Related]
16. miR-520g and miR-520h overcome bortezomib resistance in multiple myeloma via suppressing APE1. Yuan X; Ma R; Yang S; Jiang L; Wang Z; Zhu Z; Li H Cell Cycle; 2019 Jul; 18(14):1660-1669. PubMed ID: 31204563 [No Abstract] [Full Text] [Related]
17. Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells. Abdi J; Rastgoo N; Chen Y; Chen GA; Chang H BMC Cancer; 2019 Oct; 19(1):975. PubMed ID: 31638931 [TBL] [Abstract][Full Text] [Related]
18. Blockade of deubiquitinase USP7 overcomes bortezomib resistance by suppressing NF-κB signaling pathway in multiple myeloma. Yao Y; Zhang Y; Shi M; Sun Y; Chen C; Niu M; Zhang Q; Zeng L; Yao R; Li H; Yang J; Li Z; Xu K J Leukoc Biol; 2018 Dec; 104(6):1105-1115. PubMed ID: 30024656 [TBL] [Abstract][Full Text] [Related]
19. Wu H; Liu C; Yang Q; Xin C; Du J; Sun F; Zhou L Autophagy; 2020 Apr; 16(4):683-697. PubMed ID: 31242129 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD. Chen Y; Ke G; Han D; Liang S; Yang G; Wu X Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]